ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

March 31, 2000

Florida Creates State Cancer Control Program

August 10, 1979

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Too Few Minority Scientists Enter Careers In Public Health, Oncology, Bynum Reports

March 24, 1989

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010